| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25021-466-05 | 25021-466 | HUMAN PRESCRIPTION DRUG | Octreotide Acetate | octreotide acetate | INJECTION, SOLUTION | INTRAVENOUS; SUBCUTANEOUS | 20230615 | N/A | ANDA | ANDA091041 | Sagent Pharmaceuticals | OCTREOTIDE ACETATE | 200 ug/mL | 1 VIAL in 1 CARTON (25021-466-05) / 5 mL in 1 VIAL |
| 25021-467-05 | 25021-467 | HUMAN PRESCRIPTION DRUG | Octreotide Acetate | octreotide acetate | INJECTION, SOLUTION | INTRAVENOUS; SUBCUTANEOUS | 20230615 | N/A | ANDA | ANDA091041 | Sagent Pharmaceuticals | OCTREOTIDE ACETATE | 1000 ug/mL | 1 VIAL in 1 CARTON (25021-467-05) / 5 mL in 1 VIAL |